WCN26-198 The effect of Fib-4 marker on chronic kidney disease; examination of the disease course in middle-aged and elderly patients with chronic kidney disease

Read full text Summarise with VIRAT
Authors: ZAFER BURAK ÇENDE, Sibel Gökçay Bek, Sibel Balcı, Metin Ergül, Ali Erkan Duman, Erkan Dervişoğlu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic kidney disease (CKD) and hepatic steatosis are two important clinical conditions that are frequently observed together, often in association with metabolic syndrome, and they contribute significantly to the global health burden. The FIB-4 index is a widely used non-invasive marker for assessing liver fibrosis, and its systemic implications have been investigated in recent years. The objective of this research was to assess the connection between FIB-4 and kidney function.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Liver Disease Diagnosis and Treatment Acute Kidney Injury Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104290–104290
Publication date
25 March 2026
Language
EN